吕星 - 中山大学 - 肿瘤防治中心

个人简介

研究工作经历　　2011~2013年中山大学肿瘤防治中心鼻咽科住院医师　　2014~2017年中山大学肿瘤防治中心鼻咽科主治医师　　2018~至今中山大学肿瘤防治中心鼻咽科副主任医师

研究领域

鼻咽癌的个体化综合治疗及人工智能辅助诊断、治疗鼻咽癌

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1) Lu X, Qian CN, Mu YG, et al. Serum CCL2 and serum TNF-α — two new biomarkers predict bone invasion, posttreatment distant metastases and poor overall survival in nasopharyngeal carcinoma. European J Cancer, 2011;47(3):339-46. ( IF：4.944 ) 　　2) Lu X, Xiang YQ, Cao SM, et al. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in the patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment. Head and Neck Journal, 2011;33(6):780-5 (IF：2.283 ) 　　3) Lu X, Guo X, Hong MH, et al. Comparison of the short-term efficacy of two inductive chemotherapy regimens for locally advanced nasopharyngeal caricinoma: docetaxal plus carboplatin versus 5-fluorouracil plus carboplatin. Chin J Cancer. 2010; 29(2): 140-4. 　　4) Lu X, Wang FL, Guo X, et al. Favorable survival of female patients with nasopharyngeal carcinoma.　Chin J Cancer. 2012 Sep 17. [Epub ahead of print] 　　5) Li SW, Wang H, Xiang YQ, Zhang HB, Lu X, Xia WX, Zeng MS, Mai HQ, Hong MH, Guo X. Prospective study of prognostic value of Raf kinase inhibitory protein and pretreatment plasma Epstein-Barr virus DNA for distant metastasis in locoregionally advanced nasopharyngeal carcinoma. Head Neck. 2012 May 18. [Epub ahead of print] 　　6) Zhang H, Xia W, Lu X, Sun R, Wang L, Zheng L, Ye Y, Bao Y, Xiang Y, Guo X. A novel statistical prognostic score model that includes serum CXCL5 levels and clinical classification predictsrisk of disease progression and survival of nasopharyngeal carcinoma patients. PLoS One. 2013;8(2):e57830. doi: 10.1371/journal.pone.0057830. Epub 2013 Feb 28. 　　7) Xia WX, Zhang HB, Shi JL, Lu X, Wang L, Ye YF, Cao KJ, Qian CN, Guo X, Xiang YQ.A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classification. Eur J Cancer. 2013 Apr 6. pii: S0959-8049(13)00188-3. doi: 10.1016/j.ejca.2013.03.003. [Epub ahead of print]